ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy
- Author
- PARVING, Hans-Henrik1 ; DE ZEEUW, Dick2 ; BRENNER, Barry M7 ; COOPER, Mark E3 ; REMUZZI, Giuseppe4 ; LIU, Nancy5 ; LUNCEFORD, Jared5 ; SHAHINFAR, Shahnaz5 ; WONG, Peggy H5 ; LYLE, Paulette A5 ; ROSSING, Peter6
[1] Department of Medical Endocrinology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
[2] Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
[3] Danielle Alberti Memorial Centre for Diabetes Complications, Baker Medical Research Institute, Melbourne, Victoria, Australia
[4] Mario Negri Laboratories and Clinical Research Center, Ranica, Italy
[5] Merck Research Laboratories, West Point, Pennsylvania, United States
[6] Steno Diabetes Center, Gentofte, Denmark
[7] Renal Division, Brigham and Women's Hospital, Boston, Massachusetts, United States - Source
Journal of the American Society of Nephrology. 2008, Vol 19, Num 4, pp 771-779, 9 p ; ref : 29 ref
- CODEN
- JASNEU
- ISSN
- 1046-6673
- Scientific domain
- Urology, nephrology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antihypertenseur Diabète de type 2 Génotype Homme Losartan Néphrologie Néphropathie Traitement Urologie Variabilité génétique Angiotensin converting enzyme Récepteur AT1 de l'angiotensine II Angiotensine II Antagoniste angiotensine Composé non peptide Dérivé de l'imidazole Dérivé du biphényle Dérivé du tétrazole Endocrinopathie Hormone peptide Maladie métabolique Octapeptide Pathologie de l'appareil urinaire Pathologie du rein Sartan dérivé Système renin angiotensine
- Keyword (en)
- Antihypertensive agent Type 2 diabetes Genotype Human Losartan Nephrology Nephropathy Treatment Urology Genetic variability Angiotensin II Angiotensin antagonist Non peptide compound Imidazole derivatives Biphenyl derivatives Tetrazole derivatives Endocrinopathy Peptide hormone Metabolic diseases Octapeptide Urinary system disease Kidney disease Sartan derivatives Renin angiotensin system
- Keyword (es)
- Antihipertensivo Diabetes de tipo 2 Genotipo Hombre Losartán Nefrología Nefropatía Tratamiento Urología Variabilidad genética Angiotensina II Antagonista angiotensina Compuesto no péptido Imidazol derivado Bifenilo derivado Tetrazol derivado Endocrinopatía Hormona péptido Metabolismo patología Octapéptido Aparato urinario patología Riñón patología Sartan derivado Sistema renin angiotensina
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Discipline
- Endocrinopathies Nephrology. Urinary tract diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20249648
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1681/ASN.2007050582 
https://dx.doi.org/10.1681/ASN.2007050582
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1681\/ASN.2007050582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American Society of Nephrology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. Am. Soc. Nephrol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"771\";s:8:\"\u0000*\u0000epage\";s:3:\"779\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1046-6673\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PARVING\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Hans-Henrik\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:14:\"DE ZEEUW, Dick\";i:1;s:16:\"BRENNER, Barry M\";i:2;s:14:\"COOPER, Mark E\";i:3;s:17:\"REMUZZI, Giuseppe\";i:4;s:10:\"LIU, Nancy\";i:5;s:16:\"LUNCEFORD, Jared\";i:6;s:18:\"SHAHINFAR, Shahnaz\";i:7;s:13:\"WONG, Peggy H\";i:8;s:16:\"LYLE, Paulette A\";i:9;s:14:\"ROSSING, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JASNEU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1681\/ASN.2007050582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American Society of Nephrology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. Am. Soc. Nephrol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"771\";s:8:\"\u0000*\u0000epage\";s:3:\"779\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1046-6673\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PARVING\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Hans-Henrik\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:14:\"DE ZEEUW, Dick\";i:1;s:16:\"BRENNER, Barry M\";i:2;s:14:\"COOPER, Mark E\";i:3;s:17:\"REMUZZI, Giuseppe\";i:4;s:10:\"LIU, Nancy\";i:5;s:16:\"LUNCEFORD, Jared\";i:6;s:18:\"SHAHINFAR, Shahnaz\";i:7;s:13:\"WONG, Peggy H\";i:8;s:16:\"LYLE, Paulette A\";i:9;s:14:\"ROSSING, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JASNEU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1681\/ASN.2007050582\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1681\/ASN.2007050582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American Society of Nephrology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. Am. Soc. Nephrol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"771\";s:8:\"\u0000*\u0000epage\";s:3:\"779\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1046-6673\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PARVING\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Hans-Henrik\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:14:\"DE ZEEUW, Dick\";i:1;s:16:\"BRENNER, Barry M\";i:2;s:14:\"COOPER, Mark E\";i:3;s:17:\"REMUZZI, Giuseppe\";i:4;s:10:\"LIU, Nancy\";i:5;s:16:\"LUNCEFORD, Jared\";i:6;s:18:\"SHAHINFAR, Shahnaz\";i:7;s:13:\"WONG, Peggy H\";i:8;s:16:\"LYLE, Paulette A\";i:9;s:14:\"ROSSING, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JASNEU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1681\/ASN.2007050582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American Society of Nephrology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. Am. Soc. Nephrol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"771\";s:8:\"\u0000*\u0000epage\";s:3:\"779\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1046-6673\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PARVING\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Hans-Henrik\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:14:\"DE ZEEUW, Dick\";i:1;s:16:\"BRENNER, Barry M\";i:2;s:14:\"COOPER, Mark E\";i:3;s:17:\"REMUZZI, Giuseppe\";i:4;s:10:\"LIU, Nancy\";i:5;s:16:\"LUNCEFORD, Jared\";i:6;s:18:\"SHAHINFAR, Shahnaz\";i:7;s:13:\"WONG, Peggy H\";i:8;s:16:\"LYLE, Paulette A\";i:9;s:14:\"ROSSING, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JASNEU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1681\/ASN.2007050582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American Society of Nephrology\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. Am. Soc. Nephrol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"771\";s:8:\"\u0000*\u0000epage\";s:3:\"779\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1046-6673\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PARVING\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Hans-Henrik\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:14:\"DE ZEEUW, Dick\";i:1;s:16:\"BRENNER, Barry M\";i:2;s:14:\"COOPER, Mark E\";i:3;s:17:\"REMUZZI, Giuseppe\";i:4;s:10:\"LIU, Nancy\";i:5;s:16:\"LUNCEFORD, Jared\";i:6;s:18:\"SHAHINFAR, Shahnaz\";i:7;s:13:\"WONG, Peggy H\";i:8;s:16:\"LYLE, Paulette A\";i:9;s:14:\"ROSSING, Peter\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JASNEU\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
